Indication

Complement Regulatory Factor Defect

1 clinical trial

1 product

Clinical trial
Complement Regulation to Undo Systemic Harm in Preeclampsia: The CRUSH Study
Status: Terminated, Estimated PCD: 2021-12-07
Product
Eculizumab